Seminars in Nuclear Medicine
Volume 35, Issue 3 , Pages 176-185 , July 2005

Initial Staging of Lymphoma With Octreotide and Other Receptor Imaging Agents

  • Diego Ferone

      Affiliations

    • Department of Endocrinological & Metabolic Sciences, University of Genoa, Genoa, Italy.
    • Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
    • Corresponding Author InformationAddress correspondence to: Diego Ferone, MD, PhD, Department of Endocrinological and Metabolic Sciences (DiSEM), University of Genova, Viale Benedetto XV, 6, 16132 Genova, Italy.
    • ,
  • Claudia Semino

      Affiliations

    • Department of Endocrinological & Metabolic Sciences, University of Genoa, Genoa, Italy.
    • ,
  • Mara Boschetti

      Affiliations

    • Department of Endocrinological & Metabolic Sciences, University of Genoa, Genoa, Italy.
    • ,
  • Giuseppe Lucio Cascini

      Affiliations

    • Nuclear Medicine, National Cancer Institute, Fondazione G. Pascale, Naples, Italy.
    • ,
  • Francesco Minuto

      Affiliations

    • Department of Endocrinological & Metabolic Sciences, University of Genoa, Genoa, Italy.
    • Centre of Excellence for Biomedical Research, University of Genoa, Genoa, Italy.
    • ,
  • Secondo Lastoria

      Affiliations

    • Nuclear Medicine, National Cancer Institute, Fondazione G. Pascale, Naples, Italy.

References 

  1. Lamberts SW , de Herder WW , Hofland LJ . Somatostatin analogs in the diagnosis and treatment of cancer . Trends Endocrinol Metab . 2002;13:451–457
  2. Kwekkeboom D , Krenning EP , Valkema R , et al.   Peptide receptor imaging and therapy . J Nucl Med . 2000;41:1704–1713
  3. Reubi JC , Waser B , Horisberger U , et al.   In vitro and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue . Blood . 1993;82:2143–2151
  4. van Hagen PM , Krenning EP , Reubi JC , et al.   Somatostatin analogue scintigraphy of malignant lymphoma . Br J Haematol . 1993;83:75–79
  5. Lipp RW , Silly H , Ranner G , et al.   Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy . J Nucl Med . 1995;36:13–18
  6. Ivancevic V , Wormann B , Nauck C , et al.   Somatostatin receptor scintigraphy in the staging of lymphomas . Leuk Lymphoma . 1997;26:107–114
  7. Jensen RT . Editorial (Somatostatin receptor-based scintigraphy and antitumor treatment—an expanding vista?) . J Clin Endocrinol Metab . 2000;85:3507–3508
  8. Reubi JC , Schar JC , Waser B , et al.   Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use . Eur J Nucl Med . 2000;27:273–282
  9. Reubi JC . Peptide receptors as molecular targets for cancer diagnosis and therapy . Endocr Rev . 2003;24:389–427
  10. Reubi JC , Waser B . Concomitant expression of several peptide receptors in neuroendocrine tumours (molecular basis for in vivo multireceptor tumour targeting) . Eur J Nucl Med Mol Imaging . 2003;30:781–793
  11. Dalm VA , Hofland LJ , Mooy CM , et al.   Somatostatin receptors in malignant lymphomas (Targets for radiotherapy?) . J Nucl Med . 2004;45:8–16
  12. van Hagen PM , Hofland LJ , Lichtenauer-Kaligis EGR , et al.   Neuropeptides and their receptors in the immune system . Ann Med . 1999;31(suppl 2):15–22
  13. Dalm VA , van Hagen PM , van Koetsveld PM , et al.   Cortistatin rather than somatostatin as a potential endogenous ligand for somatostatin receptors in the human immune system . J Clin Endocrinol Metab . 2003;88:270–276
  14. Dalm VA , van Hagen PM , de Krijger RR , et al.   Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues . Clin Endocrinol (Oxf) . 2004;60:625–629
  15. Stanisz AM , Befus D , Bienenstock J . Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer’s patches, mesenteric lymph nodes, and spleen . J Immunol . 1986;136:152–156
  16. van Hagen PM , Krenning EP , Kwekkeboom DJ , et al.   Somatostatin and the immune and haematopoietic system (A review) . Eur J Clin Invest . 1994;24:91–99
  17. Besedovsky H , Del Rey A . Immune-neuro-endocrine interactions (Facts and hypothesis) . Endocr Rev . 1996;17:64–102
  18. Talme T , Ivanoff J , Hagglund M , et al.   Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells. Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3 . Clin Exp Immunol . 2001;125:1–9
  19. Oomen SP , Lichtenauer-Kaligis EG , Verplanke N , et al.   Somatostatin induces migration of acute myeloid leukemia cells via activation of somatostatin receptor subtype 2 . Leukemia . 2001;15:621–627
  20. Patel YC . Molecular pharmacology of somatostatin receptor subtypes . J Endocrinol Invest . 1997;20:348–367
  21. Moller LN , Stidsen CE , Hartmann B , et al.   Somatostatin receptors . Biochim Biophys Acta . 2003;1616:1–84
  22. Reubi JC , Kappeler A , Waser B , et al.   Immunohistochemical localization of somatostatin receptors sst2A in human tumors . Am J Pathol . 1998;153:233–245
  23. Hofland LJ , Liu Q , van Koetsveld PM , et al.   Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors . J Clin Endocrinol Metab . 1999;84:775–780
  24. Goetzl EJ , Chernov-Rogan T , Cooke MP , et al.   Endogenous somatostatin-like peptides in rat basophilic leukaemia cells . J Immunol . 1985;135:2707–2712
  25. Aguila MC , Dees WL , Haensly WE , et al.   Evidence that somatostatin is localized and synthesized in lymphatic organs . Proc Natl Acad Sci USA . 1991;88:11485–11489
  26. Weinstock JV , Elliott D . The somatostatin immunoregulatory circuit present at sites of chronic inflammation . Eur J Endocrinol . 2000;143(suppl 1):S15–S19
  27. Solomou K , Ritter MA , Palmer DB . Somatostatin is expressed in the murine thymus and enhances thymocyte development . Eur J Immunol . 2002;32:1550–1559
  28. Ferone D , van Hagen PM , van Koetsveld PM , et al.   In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells . Endocrinology . 1999;140:373–380
  29. Spier AD , de Lecea L . Cortistatin (A member of the somatostatin neuropeptide family with distinct physiological functions) . Brain Res Rev . 2000;33:228–241
  30. Ferone D , van Hagen PM , Colao A , et al.   Somatostatin receptors in the thymus . Ann Med . 1999;31(suppl 2):28–33
  31. Dalm VA , van Hagen PM , van Koetsveld PM , et al.   Regulation of the expression of somatostatin, cortistatin and somatostatin receptors in human monocytes, macrophages and dendritic cells . Am J Physiol Endocrinol Metab . 2003;285:E344–E353
  32. ten Bokum AM , Hofland LJ , van Hagen PM . Somatostatin and somatostatin receptors in the immune system (A review) . Eur Cytokine Netw . 2000;11:161–176
  33. Ferone D , Hofland LJ , Colao A , et al.   Neuroendocrine aspects of immunolymphoproliferative diseases . Ann Oncol . 2001;12(suppl 2): S125–S30
  34. Dalm VA , Hofland LJ , Ferone D , et al.   The role of somatostatin and somatostatin analogs in the pathophysiology of the human immune system . J Endocrinol Invest . 2003;26(suppl 8):94–102
  35. Ferone D , Arvigo M , Semino C , et al.   The role of somatostatin analogs in the management of immunoproliferative disease . J Endocrinol Invest . 2003;26(suppl 8):103–108
  36. Ferone D , van Hagen PM , Semino C , et al.   Somatostatin receptor distribution and function in immune system . Dig Liver Dis . 2004;36(suppl 1):S68–S77
  37. Reubi JC , Waser B , Horisberger U , et al.   In vitro and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue . Blood . 1993;82:2143–2151
  38. Reubi JC , Horisberger U , Kappeler A , et al.   Localization of receptors for vasoactive intestinal peptide, somatostatin and substance P in distinct compartments of human lymphoid organs . Blood . 1998;92:191–197
  39. Bhathena SJ , Louie J , Schechter GP , et al.   Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon . Diabetes . 1981;30:127–131
  40. Scicchitano R , Dazin P , Bienenstock J , et al.   Distribution of somatostatin receptors on murine spleen and Peyer’s patch T and B lymphocytes . Brain Behav Immun . 1987;1:173–184
  41. Ferone D , van Hagen PM , Colao A , et al.   Distribution, role and function of somatostatin receptors in immune cells . In:  Lamberts SWJ editors. Octreotide (The Next Decade) . Bristol, UK: BioScientifica Ltd; 1999;p. 259–275
  42. Ghamrawy CE , Rabourdin-Combe C , Krantic S . sst5 somatostatin receptor mRNA induction by mitogenic activation of human T-lymphocytes . Peptides . 1999;20:305–311
  43. Lichtenauer-Kaligis EGR , van Hagen PM , Lamberts SWJ , et al.   Somatostatin receptor subtypes in human immune cells . Eur J Endocrinol . 2000;143(suppl 1):S21–S25
  44. Lichtenauer-Kaligis EG , Dalm VA , Oomen SP , et al.   Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets . Eur J Endocrinol . 2004;150:565–577
  45. Ferone D , Pivonello R , van Hagen PM , et al.   Age-related decrease of somatostatin receptor number in the normal human thymus . Am J Physiol Endocrinol Metab . 2000;279:E791–E798
  46. Ferone D , van Hagen PM , Pivonello R , et al.   Physiological and pathophysiological role of somatostatin receptors in the human thymus . Eur J Endocrinol . 2000;143(suppl 1):S27–S34
  47. Sreedharan SP , Kodama KT , Peterson KE , et al.   Distinct subsets of somatostatin receptors on cultured human lymphocytes . J Biol Chem . 1989;264:949–952
  48. Hiruma K , Koike T , Nakamura H , et al.   Somatostatin receptors on human lymphocytes and leukaemia cells . Immunology . 1990;71:480–485
  49. Nakamura H , Koike T , Hiruma K , et al.   Identification of lymphoid cell lines bearing receptors for somatostatin . Immunology . 1987;62:655–658
  50. Tsutsumi A , Takano H , Ichikawa K , et al.   Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells . Cell Immunol . 1997;181:44–49
  51. Cardoso A , Ghamrawy GE , Gautron J-P , et al.   Somatostatin increases mitogen-induced IL-2 secretion and proliferation of human Jurkat T cells via sst3 receptor isotype . J Cell Biochem . 1998;68:62–73
  52. Georgii-Hemming P , Strömberg T , Janson ET , et al.   The somatostatin analog octreotide inhibits growth of interleukin-6 (IL6-)-dependent and IL-6-independent human multiple myeloma cell lines . Blood . 1999;93:1724–1731
  53. Sharma K , Patel YC , Srikant CB . Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest by human somatostatin receptor 3 . Mol Endocrinol . 1996;10:1688–1696
  54. Reubi JC , Waser B , van Hagen PM , et al.   In vivo and in vitro detection of somatostatin receptors in human malignant lymphomas . Int J Cancer . 1992;50:895–900
  55. van den Anker-Lugtenburg PJ , Löwenberg B , Lamberts SWJ , et al.   The relevance of somatostatin receptor expression in malignant lymphomas . Metabolism . 1996;45:96–97
  56. Lamberts SWJ , Krenning EP , Reubi JC . The role of somatostatin and its analogs in the diagnosis and treatment of tumors . Endocr Rev . 1991;12:450–482
  57. Krenning EP , Kwekkeboom DJ , Bakker WH , et al.   Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide (The Rotterdam experience with more than 1000 patients) . Eur J Nucl Med . 1993;20:716–731
  58. van Hagen PM . Somatostatin receptor expression in clinical immunology . Metabolism . 1996;45:86–87
  59. Goldsmith SJ , Macapinlac HA , O’Brien JP . Somatostatin-receptor imaging in lymphoma . Semin Nucl Med . 1995;25:262–271
  60. Kwekkeboom DJ , Krenning EP . Somatostatin receptor imaging . Semin Nucl Med . 2002;32:84–91
  61. van den Anker-Lugtenburg PJ , Krenning EP , Oei HY , et al.   Somatostatin receptor scintigraphy in the initial staging of Hodgkin’s disease . Br J Haematol . 1996;93:96–103
  62. Lugtenburg PJ , Krenning EP , Valkema R , et al.   Somatostatin receptor scintigraphy in stage I-II Hodgkin’s disease (more extended disease is identified) . Br J Haematol . 2001;112:936–944
  63. Lugtenburg PJ , Lowenberg B , Valkema R , et al.   Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin’s lymphoma . J Nucl Med . 2001;42:222–229
  64. van den Anker-Lugtenburg PJ , Heule F , van Hagen PM , et al.   Somatostatin receptor scintigraphy in cutaneous malignant lymphomas . J Am Acad Dermatol . 1996;34: 985–983
  65. Isaacson PG , Wright DH . Malignant lymphoma of mucosa-associated lymphoid tissue . A distinctive type of B-cell lymphoma. Cancer . 1983;52:1410–1416
  66. Thieblemont C , Bastion Y , Berger F , et al.   Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior (Analysis of 108 patients) . J Clin Oncol . 1997;15:1624–1630
  67. Raderer M , Valecak J , Pfeffel F , et al.   Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue type . J Natl Cancer Inst . 1999;91:716–718
  68. Raderer M , Traub T , Formanek M , et al.   Somatostatin-receptor scintigraphy for staging and follow-up of patients with extraintestinal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT)-type . Br J Cancer . 2001;85:1462–1466
  69. Morgensztern D , Rosado MF , Serafini AN , et al.   Somatostatin receptor scintigraphy in MALT lymphoma of the lacrimal gland treated with rituximab . Leuk Lymphoma . 2004;45:1275–1278
  70. Hoffmann M , Kletter K , Becherer A , et al.   18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma . Oncology . 2003;64:336–340
  71. Elstrom R , Guan L , Baker G , et al.   Utility of FDG-PET scanning in lymphoma by WHO classification . Blood . 2003;101:3875–3876
  72. Lipp RW , Schnedl WJ , Aglas F , et al.   Visualization of non-Hodgkin’s lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography . Acta Med Austriaca . 1999;26:105–108
  73. Roland J , Pickut BA , Abib A , et al.   Primary cerebral lymphoma visualized by means of In-111-pentetreotide scintigraphy . Acta Neurol Belg . 1998;98:356–359
  74. Cholewinski W , Kowalczyk JR , Stefaniak B , et al.   Diagnosis and staging of childrens’ lymphoma using the technetium labelled somatostatin analogue, 99mTc-depreotide . Eur J Nucl Med Mol Imaging . 2004;31:820–824
  75. Virgolini I , Leimer M , Handmaker H , et al.   Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829 . Cancer Res . 1998;58:1850–1859
  76. Bushnell DL , Menda Y , Madsen MT , et al.   99mTc-depreotide tumour uptake in patients with non-Hodgkin’s lymphoma . Nucl Med Commun . 2004;25:839–843
  77. Gabriel M , Decristofaro C , Donnemiller E , et al.   An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for the diagnosis of somatostatin receptor-expressing tumors . J Nucl Med . 2003;44:708–716
  78. Lastoria S , Vergara E , Palmieri G , et al.   In vivo detection of malignant thymic masses by [111In-DTPA-D-Phe1]-Octreotide scintigraphy . J Nucl Med . 1998;39:634–639
  79. Lastoria S , Palmieri G , Muto P , et al.   Functional imaging of thymic disorders . Ann Med . 1999;31(suppl 2):63–69
  80. Cadigan DG , Hollett PD , Collingwood PW , et al.   Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue . Clin Nucl Med . 1996;21:487–488
  81. Lin K , Nguyen BD , Ettinger DS , et al.   Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma . Clin Nucl Med . 1999;24:24–28
  82. Ferone D , van Hagen PM , Kwekkeboom DJ , et al.   Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro . J Clin Endocrinol Metab . 2000;85:1719–1726
  83. Ferone D , Kwekkeboom DJ , Pivonello R , et al.   In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features . J Endocrinol Invest . 2001;24:522–528
  84. Palmieri G , Lastoria S , Colao A , et al.   Successful treatment of a patient with thymoma and pure red-cell aplasia with octreotide and prednisone . N Engl J Med . 1997;336:263–265
  85. Palmieri G , Lastoria S , Montella L , et al.   Role of somatostain analogue . based therapy in unresponsive malignant thymomas. Ann Med . 1999;31(suppl 2):80–85
  86. Palmieri G , Montella L , Martinetti A , et al.   Somatostatin analogs and prednisone in advanced refractory thymic tumors . Cancer . 2002;94:1414–1420
  87. Raggi CC , Maggi M , Renzi D , et al.   Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome . J Clin Endocrinol Metab . 2000;85:3866–3873
  88. Ferone D , Pivonello R , van Hagen PM , et al.   Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes . Am J Physiol Endocrinol Metab . 2002;283:E1056–E1066
  89. Rocheville M , Lange DC , Kumar U , et al.   Receptors for dopamine and somatostatin (Formation of hetero-oligomers with enhanced functional activity) . Science . 2000;288:154–157
  90. Pfeiffer M , Koch T , Schroeder H , et al.   Homo- and heterodimerization of somatostatin receptor subtypes . Inactivation of sst3 receptor function by heterodimerization with sst2A. J Biol Chem . 2001;276:14027–14036
  91. Patel RC , Kumar U , Lamb DC , et al.   Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells . Proc Natl Acad Sci USA . 2002;99:3294–3299
  92. Froidevaux S , Eberle AN , Heppeler A , et al.   Receptor targeting for tumor localization and therapy with radiopeptides . Curr Med Chem . 2000;7:971–994

PII: S0001-2998(05)00017-6

doi: 10.1053/j.semnuclmed.2005.03.001

Seminars in Nuclear Medicine
Volume 35, Issue 3 , Pages 176-185 , July 2005

Article Tools

* Image Usage & Resolution